Print Page  Close Window


SEC Filings

8-K
OREXIGEN THERAPEUTICS, INC. filed this Form 8-K on 05/03/2019
Entire Document
 


Case 18-10518-KG     Doc 1081     Filed 04/29/19     Page 7 of 11

 

In re: Orexigen Therapeutics, Inc.

   Case No. 18-10518 (KG)

Debtor

   Reporting Period: March 1, 2019 - March 31, 2019

 

MOR - 1c

Schedule of Professional Fees and Expenses Paid

For the Period: March 1, 2019 - March 31, 2019

(Unaudited)

 

                                Month Ended 3/31/19                      Cumulative Since Filing      
Payee   Category   Payor   Date   Period Covered   Fees     Expenses     Fees     Expenses  

 

 

Retained Professionals

               

Hogan Lovells US LLP

 

Debtor Counsel

 

Orexigen Therapeutics, Inc.            

    3/12/2018 - 12/31/2018       $ 2,492,836     $ 33,877  

Morris, Nichols, Arsht & Tunnell LLP

 

Debtor Local Counsel

 

Orexigen Therapeutics, Inc.

    3/12/2018 - 12/31/2018         807,272       22,295  

Ernst & Young, LLP

 

Debtor Financial Advisor

 

Orexigen Therapeutics, Inc.

    3/12/2018 - 11/30/2018         2,151,260       202,314  

Perella Weinberg Partners

 

Debtor Investment Banker

 

Orexigen Therapeutics, Inc.

    3/12/2018 - 7/27/2018         3,411,713       3,600  

Irell & Manella LLP

 

Committee Counsel

 

Orexigen Therapeutics, Inc.

    3/12/2018 - 11/30/2018         895,713       14,874  

Berkeley Research Group LLC

 

Committee Financial Advisor

 

Orexigen Therapeutics, Inc.

    3/27/2018 - 11/30/2018         308,627       2,869  

Elliott Greenleaf, P.C.

 

Committee Local Counsel

 

Orexigen Therapeutics, Inc.

  3/25/2019   3/27/2018  - 12/31/2018     6,774       40       136,085       638  

Kurtzman Carson Consultants LLC

 

Claims Agent

 

Orexigen Therapeutics, Inc.

  3/11/2019   3/12/2018 - 1/31/2019     25,604         498,277       170,161  

Landis Rath & Cobb LLP

 

Debtor Conflict Counsel

 

Orexigen Therapeutics, Inc.

  6/14/2018 - 11/30/2018         193,955       2,191  

Other Restructuring Professionals

               

Wilmington Trust, National Association

 

DIP Administrative Agent

 

Orexigen Therapeutics, Inc.

  3/12/2018 - 7/31/2018       $ 51,600     $ -  

Arnold & Porter Kaye Scholer LLP

 

DIP Administrative Agent Counsel

 

Orexigen Therapeutics, Inc.

  3/12/2018 - 7/27/2018         131,889       1,034  

Quinn Emanuel Urquhart & Sullivan, LLP    

 

DIP Lenders Counsel

 

Orexigen Therapeutics, Inc.

  3/12/2018 - 10/31/2018         1,023,973       19,636  

Brown Rudnick LLP

 

DIP Lender Counsel

 

Orexigen Therapeutics, Inc.

  2/15/2018 - 5/31/2018         147,048       1,497  

Whiteford Taylor Preston

 

DIP Lenders Local Counsel

 

Orexigen Therapeutics, Inc.

  3/12/2018 - 12/31/2018         237,215       2,141  

U.S. Bank, N.A.

 

Indenture Trustee

 

Orexigen Therapeutics, Inc.

  3/25/2019   3/1/2018 - 1/31/2019     21,097         873,656       3,040  

Duane Morris

 

DIP Administrative Agent Secondary Counsel    

 

Orexigen Therapeutics, Inc.

    4/10/2018 - 7/27/2018         17,609       -  

 

 

Total

          $ 53,475     $ 40     $ 13,378,728     $ 480,167